» Articles » PMID: 20069079

Factors Contributing to Suboptimal Vaccination Against Influenza: Results of a Nationwide Telephone Survey of Persons with Cardiovascular Disease

Overview
Date 2010 Jan 14
PMID 20069079
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccination against influenza averts cardiovascular events and is recommended for all patients with coronary heart disease. Because data were unavailable regarding vaccination rates among such patients' household contacts, we sought to estimate the rate of influenza vaccination in persons with cardiovascular disease and their contacts. In 2004, we conducted a random, nationwide telephone survey of 1,202 adults (age, > or = 18 yr) to ascertain knowledge, attitudes, and behaviors regarding influenza vaccination. Of the interviewees, 134 (11.1%) had histories of heart disease or stroke. Of these 134, 57% were men, and 45% were > or = 65 years of age. Overall, 57% were inoculated against influenza in 2003-2004, and 68% intended the same during 2004-2005. Vaccination rates increased with age: 48% (ages, 18-49 yr), 68% (ages, 50-64 yr), and 75% (age, > or = 65 yr). Forty of 69 respondents (58%) reported that their spouses were vaccinated, and 7 of 21 (33%) reported the inoculation of children < or = 17 years old in their household. Only 65% of the 134 patients considered themselves to be of high-risk status. Chief reasons for remaining unvaccinated were disbelief in being at risk and fear of contracting influenza from the vaccine. Although seasonal influenza vaccination is recommended for all coronary heart disease patients and their household contacts, the practice is less prevalent than is optimal. Intensified approaches are needed to increase vaccination rates. These findings suggest a need to increase vaccination efforts in high-risk subjects, particularly amidst the emerging H1N1 pandemic.

Citing Articles

The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study.

Cho H, Houle S, Alsabbagh W Health Promot Chronic Dis Prev Can. 2023; 43(2):87-97.

PMID: 36794825 PMC: 10026606. DOI: 10.24095/hpcdp.43.2.04.


Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis.

Zangiabadian M, Nejadghaderi S, Mirsaeidi M, Hajikhani B, Goudarzi M, Goudarzi H Sci Rep. 2020; 10(1):20656.

PMID: 33244069 PMC: 7692477. DOI: 10.1038/s41598-020-77679-7.


Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review.

Behrouzi B, Araujo Campoverde M, Liang K, Talbot H, Bogoch I, McGeer A J Am Coll Cardiol. 2020; 76(15):1777-1794.

PMID: 33032740 PMC: 7535809. DOI: 10.1016/j.jacc.2020.08.028.


Flu vaccination among older persons: study of knowledge and practices.

Gazibara T, Kovacevic N, Kisic-Tepavcevic D, Nurkovic S, Kurtagic I, Gazibara T J Health Popul Nutr. 2019; 38(1):2.

PMID: 30606257 PMC: 6318864. DOI: 10.1186/s41043-018-0159-8.


A Blueprint for Improving the Promotion and Delivery of Adult Vaccination in the United States.

Harris K, Uscher-Pines L, Mattke S, Kellermann A Rand Health Q. 2017; 2(1):15.

PMID: 28083237 PMC: 4945297.


References
1.
Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W . Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000; 102(25):3039-45. DOI: 10.1161/01.cir.102.25.3039. View

2.
Madjid M, Naghavi M, Litovsky S, Casscells S . Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003; 108(22):2730-6. DOI: 10.1161/01.CIR.0000102380.47012.92. View

3.
. Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR Morb Mortal Wkly Rep. 2005; 54(34):850. View

4.
Jackson L, Yu O, Heckbert S, Psaty B, Malais D, Barlow W . Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol. 2002; 156(7):634-40. DOI: 10.1093/aje/kwf073. View

5.
. Influenza vaccination levels among persons aged > or =65 years and among persons aged 18-64 years with high-risk conditions--United States, 2003. MMWR Morb Mortal Wkly Rep. 2005; 54(41):1045-9. View